Justin Ye
Research Subjects
Justin Ye has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan Anthony Ellman
Yale University
1 shared publication - Na Yeon Kwon
Department of Chemistry
1 shared publication
Latest Publications
- Open Access
- 27 April 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (17) , 18243-18255
Asymmetric Synthesis of S -Trifluoromethyl Sulfoxide and Sulfoximine Pharmacophores
Chiral sulfoxides and sulfoximines are present in many approved drugs and clinical candidates, and as predicated by the extensive use of the trifluoromethyl group in medicinal chemistry, S-trifluoromethyl derivatives with potent biological activity have been reported. However, chiral S-trifluoromethyl sulfoxides and sulfoximines are underexplored, perhaps because the only published routes for their preparation proceed by racemic synthesis followed by chiral separation. Here we report the asymmetric syntheses of S-trifluoromethyl sulfoxides and sulfoximines utilizing highly enantioenriched S-trifluoromethyl sulfilimines as common intermediates, obtained by the enantioselective copper-catalyzed S-trifluoromethylation of a wide range of sulfenamides, including complex drug and natural product derivatives. Methods were developed for the efficient conversion of the S-trifluoromethyl sulfilimines to sulfoxides via hydrolysis with inversion and sulfoximines via oxidation with retention. Mechanistic studies of the conversion of S-trifluoromethyl sulfilimines to sulfoxides reveal that the sulfilimine N-acyl group is first cleaved to give the free-NH sulfilimine that then undergoes hydrolysis by backside displacement of the amine to give the sulfoxide with inversion of stereochemistry.
- 27 April 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (17) , 18243-18255
Open AccessAsymmetric Synthesis of S -Trifluoromethyl Sulfoxide and Sulfoximine Pharmacophores
Chiral sulfoxides and sulfoximines are present in many approved drugs and clinical candidates, and as predicated by the extensive use of the trifluoromethyl group in medicinal chemistry, S-trifluoromethyl derivatives with potent biological activity have been reported. However, chiral S-trifluoromethyl sulfoxides and sulfoximines are underexplored, perhaps because the only published routes for their preparation proceed by racemic synthesis followed by chiral separation. Here we report the asymmetric syntheses of S-trifluoromethyl sulfoxides and sulfoximines utilizing highly enantioenriched S-trifluoromethyl sulfilimines as common intermediates, obtained by the enantioselective copper-catalyzed S-trifluoromethylation of a wide range of sulfenamides, including complex drug and natural product derivatives. Methods were developed for the efficient conversion of the S-trifluoromethyl sulfilimines to sulfoxides via hydrolysis with inversion and sulfoximines via oxidation with retention. Mechanistic studies of the conversion of S-trifluoromethyl sulfilimines to sulfoxides reveal that the sulfilimine N-acyl group is first cleaved to give the free-NH sulfilimine that then undergoes hydrolysis by backside displacement of the amine to give the sulfoxide with inversion of stereochemistry.